Literature DB >> 2890433

Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-beta 1.

J Keski-Oja1, R M Lyons, H L Moses.   

Abstract

In an attempt to identify and quantitate latent and active forms of transforming growth factor beta (TGF beta) without the use of cell cultures and to test for autocrine stimulation by TGF beta, rabbit antibodies were raised against native human and porcine platelet-derived TGF beta. A radioimmunoassay for TGF beta was developed using radioiodinated TGF beta, anti-TGF beta antibodies, and protein A. Inhibition in the radioimmunoassay was achieved with nanogram quantities of TGF beta, comparable to the sensitivity of radioreceptor assays. Analyses of the TGF beta levels of conditioned medium from cultured cells indicated that the latent form(s) of TGF beta is not detectable in the radioimmunoassay established using antibodies raised against native TGF beta. Immunoprecipitation analysis of radiolabeled conditioned medium revealed a specific Mr 25,000 band only after acidification. A Mr 62,000 protein was observed with and without prior acidification of the medium but could not be competed with unlabeled TGF beta in the immunoprecipitation indicating antigenic unrelatedness. The anti-TGF beta IgG inhibited the binding of [125I]TGF beta to the cell surface receptors in a radioreceptor assay. TGF beta inhibition of A549 cell growth was reversed by the antibodies, which also neutralized the growth inhibitory effects of TGF beta on AKR-2B cells in a monolayer [3H]thymidine incorporation assay as demonstrated by prevention of TGF beta inhibition of insulin and epidermal growth factor-stimulated DNA synthesis. The antibodies also effectively inhibited spontaneous soft agar growth of AKR-MCA fibroblasts, providing evidence for autocrine secretion of TGF beta as a mechanism of their anchorage-independent growth.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2890433

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

1.  Dynamics of Vascular Remodeling: An Overview and Bibliography.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

2.  Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.

Authors:  G H Gibbons; R E Pratt; V J Dzau
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

3.  Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor.

Authors:  P A Dennis; D B Rifkin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

4.  Dexamethasone and 1,25(OH)2 vitamin D3 modulate the synthesis of insulin-like growth factor-I in osteoblast-like cells.

Authors:  T L Chen; J B Mallory; R L Hintz
Journal:  Calcif Tissue Int       Date:  1991-04       Impact factor: 4.333

5.  Fluid shear stress induces endothelial transforming growth factor beta-1 transcription and production. Modulation by potassium channel blockade.

Authors:  M Ohno; J P Cooke; V J Dzau; G H Gibbons
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

6.  Transforming growth factor-beta activity in sheep lung lymph during the development of pulmonary hypertension.

Authors:  E A Perkett; R M Lyons; H L Moses; K L Brigham; B Meyrick
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

7.  Erbin and the NF2 tumor suppressor Merlin cooperatively regulate cell-type-specific activation of PAK2 by TGF-beta.

Authors:  Mark C Wilkes; Claire E Repellin; Min Hong; Margarita Bracamonte; Sumedha G Penheiter; Jean-Paul Borg; Edward B Leof
Journal:  Dev Cell       Date:  2009-03       Impact factor: 12.270

Review 8.  Growth factors and tyrosine protein kinases in normal and malignant melanocytes.

Authors:  R Halaban
Journal:  Cancer Metastasis Rev       Date:  1991-06       Impact factor: 9.264

9.  Modulation of transforming growth factor-beta 1 antiproliferative effects on endothelial cells by cysteine, cystine, and N-acetylcysteine.

Authors:  S K Das; A C White; B L Fanburg
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

Review 10.  Transforming growth factor beta and the cell surface in tumor progression.

Authors:  M J Newman
Journal:  Cancer Metastasis Rev       Date:  1993-09       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.